Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

This study addresses the gap in understanding the prognostic relevance of hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression in metastatic cervical squamous cell carcinoma (SCC) patients undergoing anti-vascular endothelial growth factor-based therapy. A retrospective multicenter study (n =...

Full description

Bibliographic Details
Main Authors: Hasan Cagri Yildirim, Hicran Anik, Deniz Ates Ozdemir, Rashad Ismayilov, Arif Akyildiz, Kerim Cayiroz, Fahri Ceyhan, Oguzalp Kavruk, Deniz Can Guven, Ozturk Ates, Alp Usubutun, Zafer Arik
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-03-01
Series:Biomolecules & Biomedicine
Subjects:
Metastatic cervical cancer
squamous cell carcinoma (SCC)
vascular endothelial growth factor (VEGF)
hypoxia-inducible factor-1 alpha (HIF-1 alpha)
bevacizumab
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/10255

Internet

https://www.bjbms.org/ojs/index.php/bjbms/article/view/10255

Similar Items